INTRODUCTION: This study describes the types and health consequences of medication errors in residential facilities for which the Danish Poison Information Center (DPIC) was contacted.
METHODS: This study is based on all inquiries made by residential facilities to the DPIC during a 13-month period. Information about inquirers and residents, data related to the medication error, symptoms, risk assessments and recommendations was collected, and a follow-up phone call was made to evaluate the clinical outcomes, preferably within one week.
RESULTS: During the study period, the DPIC received 146 inquiries concerning medication errors in residential facilities. Nearly all inquiries concerned excess administration of medication (96%) and often involved medications targeting the nervous system (65%). In 9% of cases, the DPIC recommended hospitalisation. Most medication errors (92%) were considered of “no or minor risk”. Administration of medication to the wrong resident is a frequent reason for consulting the DPIC (45%) in cases with medication errors.
CONCLUSIONS: In this study, we inventoried the inquiries made to the DPIC about medication errors in residential facilities in Denmark. Most medication errors did not carry a risk of serious health consequences, but continued monitoring is warranted to minimise risk in this vulnerable population.
FUNDING: Copenhagen Center for Health Technology (5001105002), Department of Clinical Pharmacology (Bispebjerg Hospital, The Capital Region) (1152871001).
TRIAL REGISTRATION: not relevant.
The majority of people living in residential facilities suffer from mental disability and have schizophrenia, anxiety, autism, Down syndrome, cerebral palsy or acquired brain injury, among other diagnoses . Residential facilities are not necessarily equipped as treatment facilities [1-3], but their residents often take several medications  and approximately two-thirds need help with medication administration . Both factors generate a risk of medication errors , which can be defined as “an unintended failure in the drug treatment process that leads to, or has the potential to lead to, harm to the patient” . If a medication error has occurred, cognitive impairment or psychiatric disease might limit the patient’s cooperation to treatment or hospitalisation.
In Denmark, all unintended medication events should be reported to the Danish Patient Safety Authority (DPSA) . According to DPSA oversight data from 2017, residential facilities had many problems with medication, and 36% of residential facilities did not meet the national requirements for medication lists to be clear and systematic . Data from the DPSA also show that the number of medication errors in Denmark at residential facilities increased from 15,000 per year in 2015 to 22,000 per year in 2019 . The severity of these errors is unknown, and it remains unclear if the upsurge is due to an increased focus and/or also reflects a true increase in the incidence of medication errors.
The Danish Poison Information Center (DPIC) was opened in 2006 to phone calls from the public and receives inquiries about actual and potential intoxications. Data from the DPIC may be used to explore if an increase has occurred in the number of inquiries concerning medication errors in residential facilities and to evaluate the nature and outcome of these errors. Thus, the aim of our study was to describe types and consequences of medication errors occurring in Danish residential facilities over a 13-month period based on prospectively registered data from the DPIC. Additionally, we investigated the number of inquiries to the DPIC concerning residential facilities from 2006 to 2019 and explored any differences in the number of inquiries within this period.
We collected data on the total number of inquiries and the number of inquiries from residential facilities from the DPIC database for the period from the DPIC database was established to the end of the study period (from 15 August 2006 to 31 December 2019).
In addition, we prospectively collected data on inquiries to the DPIC regarding medication errors in residential facilities from 1 March 2018 to 31 March 2019. Nurses with toxicological training collected the following data: educational background of the inquirer, resident characteristics (sex, age, diagnosis) and data related to the medication error (the medicine(s) involved, time and date, time between error and inquiry), symptoms, risk assessment (risk of developing: 1) “no/minor”, 2) “manifest” (i.e. moderate or severe), 3) “life- threatening” poisoning or 4) “non-evaluable risk” based on the anamnestically reported clinical presentation/symptomatology, type of medication(s) involved, significant comorbidity and/or relevant laboratory abnormalities) and recommendation for treatment/observation (“observation at home”, i.e. in the residential facility or “admission to hospital”). To evaluate clinical outcomes, follow-up phone calls to the residential facility were attempted within one week.
Descriptive analyses were performed and a graphical presentation was prepared. The study was approved by the Danish Data Protection Agency (2012-58-0004). Data collection was performed as part of a quality project, and data were anonymised prior to analyses. No ethical approval was necessary. Reporting was in accordance with the STROBE guideline .
Trial registration: not relevant.
Development in inquiries 2006-2019
As shown in Figure 1, a total of 683 inquiries concerning medication errors in residential facilities were made to the DPIC in the period from 2006 to 2019. The annual number of inquiries from residential facilities increased over time and was particularly high in 2018-2019. In the primary risk assessment of these inquiries, the medication errors were evaluated as having or constituting a risk of either “no or minor” (74%, 507/683), “manifest” (19%, 129/683) or “life-threatening” (0.4%, 3/683) poisoning, whereas 4% (44/683) were non-evaluable. The total annual number of inquiries from the whole community also increased over this time period (Figure 1).
Prospective study period 2018- 2019
During the 13-month prospective registration period, the DPIC received a total of 34,103 inquiries. Of these, 146 (0.43%, 146/34,103) concerned medication errors in residential facilities.
In 63% (92/146) of the cases, the medication error concerned male residents. The median age of the residents was 49 (range: 12-84) years. Overall, 18% (27/146) had a psychiatric diagnosis, 44% (64/146) had a neurological diagnosis and for 38% (55/146) a diagnosis was not reported. The majority of inquiries were made by personnel at residential facilities (96%, 140/146) (Figure 2). Most often, healthcare professionals (45%, 65/146) or pedagogical staff (33%, 48/146) made the inquiry. In 23% (33/146), the educational background was unknown. Inquiries were made primarily during daytime (47%, 68/146) or evening (51%, 74/146) shifts. In 46% (67/146) of cases, the inquiry was made within 30 minutes after the medication error.
Types of medication errors
Most errors involved “administration of excess/too much medicine” (96%, 140/146) (Figure 3). Administration to the wrong resident constituted 45% (66/146) of the cases. Regarding the errors involving the residents’ own medication, 26% (19/74) were due to administration at an incorrect time (i.e. evening medication given in the morning), whereas 73% (54/74) concerned administration of twice the prescribed dose or more. In cases involving administration of excess medication, the medication error involved one drug in 51% (71/140) of cases, whereas in 49% (69/140) of the cases, two or more medications were involved.
In total, 313 over-the-counter and prescription medications were involved in the errors, mostly medication affecting the nervous system (65%, 202/313) (Table 1). Within this group, most errors concerned anti-epileptics (28%, 88/313) and psycholeptics (25%, 79/313).
Adherence to recommendations
Figure 2 presents the distribution of inquiries from residential facilities or a (pre-)hospital setting, as well as the recommendation, risk assessment and place for observation. The DPIC recommended observation at home (in accustomed surroundings at the residential facility) in 91% (133/146) of cases and hospitalisation in 9% (13/146) of cases.
In the 140 cases in which the call was made by the residential facility, the DPIC recommended observation at home in 93% (130/140) of cases and hospitalisation in 7% (10/140). Among the inquiries from the residential facilities, the recommendation from the DPIC for observation at home was followed in 95% (123/130) and a recommendation for hospitalisation was followed in 70% (7/10) of cases.
The DPIC categorised most residents as having “no or a minor risk” of poisoning (92%, 133/146). Only 11% (16/146) of residents had developed symptoms at the time of inquiry. None of the medication errors were assessed as “life-threatening”, but 8% (12/146) were considered to carry a risk of developing or had already developed into a “manifest” poisoning. Most of these residents (67%, 8/12) had taken/received the medication intended for another resident, and in all these cases the DPIC recommended hospitalisation.
Development of symptoms
Among cases with available follow-up data, 34% (47/138) of residents developed symptoms between the inquiry and follow-up, whereas 60% (83/138) were asymptomatic. For 6% (8/138), data on symptoms between the inquiry and follow-up were not registered. One resident (0.7%, 1/138) had a chronic poisoning and symptoms had not resolved at follow-up, whereas the remaining residents (99%, 137/138) seemed to be in recovery or had recovered from symptoms by the time of follow-up.
From 2006 to 2019, an increasing number of inquiries were reported from residential facilities concerning medication errors. During the 13-month prospective registration in 2018-2019, the DPIC was consulted about 146 medication errors in residential facilities. Nearly all (96%) of the errors involved excess administration of medications, whereas skipped doses/medications and incorrect administration routes were rarely consulted with the DPIC. In 45% of inquiries, medication was administered to a wrong resident. Medications affecting the nervous system were most often involved, especially anti-epileptics and psycholeptics. The DPIC recommended hospitalisation in 9% of cases. Follow-up was obtained for 95% of inquiries, and all residents with acute overdoses had recovered or seemed to be in recovery from any symptoms at this time.
Limitations and strengths
This study has a limited sample size and likely represents a highly selected population as the inquirer needs to be familiar with the DPIC. Hence, the findings may not necessarily be representative of the medication errors taking place at residential facilities. Furthermore, some errors may have been handled internally or conferred elsewhere. It is also possible that the errors for which the DPIC was contacted were considered to have a high potential for toxicity as opposed to, for instance, errors involving forgotten (or too low) doses. Some residents may have difficulties expressing symptoms, and therefore the reported number of residents experiencing milder/moderate symptoms may have been underestimated.
This study has several strengths, including the prospective design and follow-up. The Poison Information Center can gather detailed information that is otherwise hard to obtain about errors in a nationwide non-hospital setting. Medication administration in Danish residential facilities is often handled by pedagogical staff [1, 3], who represented 33% of the inquirers in our study. Sufficient knowledge about medications is important to diminish the occurrence of medication errors  and it seems possible that improved knowledge may prevent some errors . Thus, the findings from this study may be used to establish educational interventions aiming to improve medication knowledge and prevent future errors.
Several reports have investigated medication errors in residential facilities [1-4], but, to our knowledge, this is the first study to investigate medication errors in this setting based on inquiries made to a national poison centre.
An increase was observed in inquiries during the 2006-2019 period, both overall and from residential facilities. The number of inquiries from residential facilities in 2018-2019 is particularly high, which may be due to an increased awareness as detailed information was collected by the DPIC staff concerning these inquiries. However, this is probably not the only explanation as an increase was also present before. Increased focus on medication errors at the residential facilities due to oversight by the health authorities and media attention likely also contributed [2-4]. However, there is also a risk that the increase may be explained by increased bustle, personnel without a healthcare background, stress when handling medications, etc. .
Medication errors have almost exclusively been studied in in-patient settings [9, 10]. A Japanese study argues that patients in long-term psychiatric hospitals share similarities with the residents of a variety of community settings in the US, UK and Europe . In our study, 45% of errors involved administration to wrong residents, whereas the corresponding percentage in the Japanese study was 36% . Other studies report much lower frequencies for this type of error, i.e. 4% in a psychiatric hospital, where nurses exclusively administer medications  and 2.6-3.1% of all inadvertent medication events in Danish residential facilities . A possible explanation for our higher percentage of errors involving administration to a wrong resident may be that inquirers have a lower threshold for consulting the DPIC with this type of error. Administration of an incorrect drug potentially leads to more serious adverse events than an incorrect administration time or dose .
An overall admission rate of 9% in our data seems comparable to US studies based on data from the US Poison Control Centers concerning medication errors in the community with antidepressants and antipsychotics  and anticonvulsives , where 8.3% and 15%, respectively, resulted in hospitalisation. In line with our study, the US Poison Control Center reported that few inquiries resulted in major medical outcomes or death, but some had a potential for severe toxicity [13, 14]. Drug errors typically do not have serious adverse health consequences, but they all deserve attention as we might provide insight into how we may diminish their risk .
Overall, an increase was observed in the number of inquiries made from residential facilities to the DPIC from 2006 to 2019. During 13 months in 2018-2019, the DPIC was consulted about 146 medication errors occurring in residential facilities. Nearly all inquiries concerned the administration of excessive amounts of medications – most often administration of medications targeting the nervous system to an incorrect resident. In 9% of cases, the DPIC recommended hospitalisation, but most medication errors were considered as carrying “no or minor” risk of poisoning. At follow-up, all residents with acute overdoses seemed to be in recovery or had recovered from any symptoms experienced due to the medication overdose.
Correspondence Mikkel Bring Christensen. E-mail: email@example.com
Accepted 16 March 2021
Conflicts of interest Potential conflicts of interest have been declared. Disclosure forms provided by the authors are available with the article at ugeskriftet.dk/dmj
Kommunernes Landsforening. Rapport: Afdækning af sundhedsindsatser på de sociale botilbud. Copenhagen: Kommunernes Landsforening. https://www.kl.dk/media/15832/afd-kning_af_sundhedsindsatser_p-_de_sociale_botil.pdf (25 Aug 2020).
Danish Patient Safety Authority. Erfaringsopsamling fra det risikobaserede tilsyn 2017. Copenhagen: Danish Patient Safety Authority, 2018. https://stps.dk/da/udgivelser/2018/bosteder-erfaringsopsamling-fra-det-risikobaserede-tilsyn-2017/ (25 Aug 2020).
National Agency for Patient Rights and Complaints. Medicinering i botilbud og øvrige tilbud til borgere med handikap-identifikation af utilsigtede hændelser og forslag til forebyggende tiltag. Frederiksberg: Patientombuddet, 2013. https://stps.dk/da/udgivelser/2013/medicinering-i-botilbud-og-oevrige-tilbud-til-borgere-med-handicap/~/media/C48278E65CC04E56A04A7A6A35EF04BA.ashx (25 Aug 2020).
Pharmakon. Øget sikkerhed i medicineringen på botilbud for personer med handikap. Hillerød: Pharmakon, 2011. https://handicap.dk/sites/handicap.dk/files/media/document/%C3%B8get-sikkerhed-i-medicineringen-paa-botilbud-for-personer-med-handicap%20%281%29.pdf (25 Aug 2020).
World Health Organization. Medication Errors: Technical Series on Safer Primary Care. Geneva: World Health Organization, 2016. https://www.who.int/patientsafety/topics/primary-care/technical_series/en/ (25 Aug 2020).
European Medicines Agency. Good practice guide on recording, coding, reporting and assessment of medication errors. London: European Medicines Agency, 2015. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-recording-coding-reporting-assessment-medication-errors_en.pdf (25 Aug 2020).
Pinborg K. Bosteder indberettede 22.000 medicinfejl i 2019. Kommunal Sundhed, 2020. https://kommunalsundhed.dk/bosteder-indberettede-22-000-medicinfejl-i-2019/ (25 Aug 2020).
von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495-9.
Procyshyn RM, Barr AM, Brickell T et al. Medication errors in psychiatry: a comprehensive review. CNS drugs 2010;24:595-609.
Maidment ID, Lelliott P, Paton C. Medication errors in mental healthcare: a systematic review. Qual Saf Health Care 2006;15:409-13.
Ito H, Yamazumi S. Common types of medication errors on long-term psychiatric care units. Int J Qual Health Care 2003;15:207-12.
Haw CM, Dickens G, Stubbs J. A review of medication administration errors reported in a large psychiatric hospital in the United Kingdom. Psychiatric Serv 2005;56:1610-3.
Kamboj A, Spiller HA, Casavant MJ et al. Antidepressant and antipsychotic medication errors reported to United States poison control centers. Pharmacoepidemiol Drug Saf 2018;27:902-11.
DeDonato EA, Spiller HA, Casavant MJ et al. Non-health care facility anticonvulsant medication errors in the United States. Human Experiment Toxicol 2018;37:561-70.
Van Den Bemt PMLA, Robertz R, De Jong AL et al. Drug administration errors in an institution for individuals with intellectual disability: an observational study. J Intellect Dis Res 2007;51:528-36.